Toby Maher
@TobyMMaher
Followers
3K
Following
588
Statuses
717
Director of ILD @KeckMedUSC. @asthmalunguk Prof of Respiratory Research, @imperialNHLI Prof of Interstitial Lung Disease and #IPF doctor. Working to #cureIPF
Los Angeles, CA
Joined March 2012
RT @JAMA_current: @LRSorce @SebastianPalmqv @NiklasMattsson4 @criticcaredoc Most Viewed JAMA 2024: Interstitial Lung Disease 🔗 https://t.co…
0
4
0
RT @sclerodermaUM: Happy holidays everyone! We are late this year but here is the link to the 5th international symposium on ILDs in rheuma…
0
18
0
RT @PureTechH: We are thrilled to share positive topline data from our ELEVATE IPF Phase 2b trial evaluating deupirfenidone (LYT-100) for t…
0
5
0
RT @HealioPulm: ❗Patients with idiopathic pulmonary fibrosis (#IPF) had less #FVC decline between baseline and 26 weeks with receipt of thr…
0
2
0
RT @KaminskiMed: Wow! Boehringer-Ingelheim announces that Nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study -…
0
33
0
RT @ATSBlueEditor: Thanks to Tom McLellan, BA, MA, MRCP, for his contribution to the August 15 issue Deep Learning–based Segmentation of C…
0
6
0
RT @KaminskiMed: I guess that's a sign of success - the day after I posted that the #ILDImmuneCellAtals was up - the website crushed becaus…
0
3
0
RT @adbyrne: Type 1 Invariant Natural Killer T Cells Drive Lung Fibrosis. Our latest work in press now @ATSBlueEditor Great collaborative p…
0
4
0
RT @KaminskiMed: Congratulations Dr. Selman for #ATS2024 Amberson Award! I wish could be there - but will cheer from New Haven!! And yes, y…
0
10
0
RT @ATSCPAssembly: An ILD Mini Symposium you won't want to miss! 👉Towards Implementation: New Biomarkers in ILD ⏰ May 19, 9:15-11:15AM 📍Mar…
0
5
0
RT @sclerodermaUM: Delighted to launch CONQUEST platform clinical trial in early SSc with ILD. It took @srfcure Luke Evnin and me 10 years…
0
5
0
The AJRCCM ILD special issue is now out. We highlight some truly exciting research. Thanks to all the authors for their support of @ATSBlueEditor. For a quick summary of what has been published in the special issue you can read our ILD editors’ editorial.
0
10
51
RT @JAMA_current: Director of the interstitial lung disease unit at @KeckMedicineUSC @TobyMMaher discusses the diagnosis and management of…
0
3
0
RT @KaminskiMed: So excited to see Dr. Paul Noble, a superb member & leader of the #CurePF4All community, take over as President of the Ass…
0
3
0
RT @drphilmol: Predicting progressive disease and mortality in IPF using automated analysis of CT scans. A massive collaborative effort bet…
0
19
0
RT @KaminskiMed: Great example of value of patient registries, machine learning & proteomics in Interstitial Lung Disease! "Machine Learnin…
0
11
0
RT @TamesideGroup: I am so fed up of this bloody awful incurable, terminal disease that is Pulmonary Fibrosis 🥺 Watching my hubby struggle…
0
3
0
RT @Worldsclerofnd: 🧬 Dive into the 4TH International Symposium on Interstitial Lung Disease in Rheumatic Diseases 👩‍💻 Participation is c…
0
20
0